Begleiter A, Leith M K, McClarty G, Beenken S, Goldenberg G J, Wright J A
Department of Internal Medicine, University of Manitoba, Winnipeg, Canada.
Cancer Res. 1988 Apr 1;48(7):1727-35.
The exact contribution of the quinone group to the activity of quinone antitumor agents remains uncertain. Two L5178Y murine lymphoblastic cell lines resistant to the model quinone antitumor agent, hydrolyzed benzoquinone mustard, and one partial-revertant cell line were isolated and characterized. The antitumor activity of hydrolyzed benzoquinone mustard has been shown previously to be due to its ability to induce free radical mediated DNA strand breaks. Resistant cells were obtained by growing a cloned L5178Y parental cell line in media containing increasing concentrations of hydrolyzed benzoquinone mustard. L5178Y/HBM2 cells were selected from L5178Y cells growing in media containing 0.2 mM drug, while L5178Y/HBM10 cells were selected from cells growing in media containing 1.0 mM drug. The L5178Y/HBMR cells were obtained by growing L5178Y/HBM10 cells in media without hydrolyzed benzoquinone mustard. The resistant cell lines, L5178Y/HBM2 and L5178Y/HBM10, were 2.5- and 6-fold less sensitive, respectively, to hydrolyzed benzoquinone mustard compared to parental cells, and this was accompanied by a decrease in the formation of DNA single and double strand breaks by this drug. The partial-revertant cell line, L5178Y/HBMR was 2.9-fold less sensitive to hydrolyzed benzoquinone mustard compared to parental cells. Drug uptake appeared to be lower in the resistant cells compared to parental cells. The resistant cells had a slightly elevated level of superoxide dismutase activity compared to parental cells, but there was no increase in the mRNA for superoxide dismutase nor any amplification of the gene for this enzyme. Intracellular catalase activities of the L5178Y/HBM2 and L5178Y/HBM10 cells were elevated by 1.25- and 2.6-fold, respectively, and the increased enzyme activity in the L5178Y/HBM10 cells appeared to result from a 3.6-fold increase in mRNA for this enzyme. Glutathione peroxidase activity was slightly elevated in L5178Y/HBM2 cells, but was unchanged in the other resistant cells. The L5178Y/HBM2 and L5178Y/HBM10 cells showed increased concentrations of glutathione and elevated levels of glutathione transferase activity. The resistant cell lines also had DT-diaphorase activity that was 3- and 24-fold higher in L5178Y/HBM2 and L5178Y/HBM10 cells, respectively, compared to sensitive cells. However, cytochrome P-450 reductase activity and the ratio of reduced to oxidized pyridine nucleotides was unchanged in the resistant cell lines. The partial-revertant cell line, L5178Y/HBMR, showed approximately the same level of resistance to hydrolyzed benzoquinone mustard as the L5178Y/HBM2 cells.(ABSTRACT TRUNCATED AT 400 WORDS)
醌基团对醌类抗肿瘤药物活性的确切贡献仍不确定。我们分离并鉴定了两种对模型醌类抗肿瘤药物水解苯醌氮芥具有抗性的L5178Y小鼠淋巴细胞系,以及一种部分回复突变细胞系。先前已表明水解苯醌氮芥的抗肿瘤活性归因于其诱导自由基介导的DNA链断裂的能力。通过在含有浓度不断增加的水解苯醌氮芥的培养基中培养克隆的L5178Y亲本细胞系获得抗性细胞。L5178Y/HBM2细胞是从在含有0.2 mM药物的培养基中生长的L5178Y细胞中筛选出来的,而L5178Y/HBM10细胞是从在含有1.0 mM药物的培养基中生长的细胞中筛选出来的。L5178Y/HBMR细胞是通过在不含水解苯醌氮芥的培养基中培养L5178Y/HBM10细胞获得的。抗性细胞系L5178Y/HBM2和L5178Y/HBM10对水解苯醌氮芥的敏感性分别比亲本细胞低2.5倍和6倍,同时该药物诱导的DNA单链和双链断裂的形成也减少。部分回复突变细胞系L5178Y/HBMR对水解苯醌氮芥的敏感性比亲本细胞低2.9倍。与亲本细胞相比,抗性细胞中的药物摄取似乎较低。与亲本细胞相比,抗性细胞中超氧化物歧化酶活性略有升高,但超氧化物歧化酶的mRNA没有增加,该酶的基因也没有扩增。L5178Y/HBM2和L5178Y/HBM10细胞的细胞内过氧化氢酶活性分别升高了1.25倍和2.6倍,L5178Y/HBM10细胞中酶活性的增加似乎是由于该酶的mRNA增加了3.6倍。L5178Y/HBM2细胞中的谷胱甘肽过氧化物酶活性略有升高,但其他抗性细胞中的该活性没有变化。L5178Y/HBM2和L5178Y/HBM10细胞中谷胱甘肽浓度增加,谷胱甘肽转移酶活性水平升高。抗性细胞系还具有DT-黄递酶活性,L5178Y/HBM2和L5178Y/HBM10细胞中的该活性分别比敏感细胞高3倍和24倍。然而,抗性细胞系中的细胞色素P-450还原酶活性以及还原型与氧化型吡啶核苷酸的比率没有变化。部分回复突变细胞系L5178Y/HBMR对水解苯醌氮芥的抗性水平与L5178Y/HBM2细胞大致相同。(摘要截短至400字)